Diabetes study pulled before it started: GLP-1 heart protection trial cancelled
NCT ID NCT04355832
First seen Nov 10, 2025 · Last updated May 20, 2026 · Updated 21 times
Summary
This study was designed to see if a hormone called GLP-1 could protect blood vessels during repeated low blood sugar episodes in people with type 1 diabetes. It planned to enroll 40 adults aged 18-50. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE1 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Maryland
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.